North America / «Grindeks» worldwide / «Grindeks» - leading pharmaceutical company in Baltics / Leading pharmaceutical company in the Baltic

«Grindeks» mission, vision and values
Governance and management
«Grindeks» worldwide
Europe
Asia
Africa
South America
North America
Central America
Australia and Oceania
All regions
EU projects
Corporate Social Responsibility
History
Cooperation
«Grindeks» corporate film
«Grindeks» Road to achievements
Virtual tour of «Grindeks»
Greeting

Print
Send

North America

USA

JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to the USA under the exclusivity agreement with the company GDL International. Cooperation with this company is developed with the aim of research, development and manufacturing of active substances for the veterinary market.

Mexico

Since 2010, JSC «Grindeks» is exporting active pharmaceutical ingredient Xylazine to Mexico.

Canada

JSC «Grindeks» started cooperation with Canada in 2004. «Grindeks» exports active pharmaceutical ingredients Oxytocine, Droperidol and Xylazine to Canada.

Home
Up
back